Background Treatment with angiotensin-converting–enzyme (ACE) inhibitors reduces
mortality among survivors of acute myocardial infarction, but whether to use ACE inhibitors …

Abstract The TRAndolapril Cardiac Evaluation (TRACE) study is evaluating the effect of
angiotensin-converting enzyme inhibition with trandolapril on mortality (overall and …

OBJECTIVES This study evaluated the efficacy of long-term treatment with the angiotensin-
converting enzyme (ACE) inhibitor trandolapril in diabetic patients with left ventricular …

Background Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing the
risk of heart failure, myocardial infarction, and death from cardiovascular causes in patients …

Background The survival benefit from the use of inhibitors of angiotensin-converting enzyme
(ACE) in patients with acute myocardial infarction is usually presented in terms of risk ratios …

In mortality studies of patients after acute myocardial infarction (AMI), exclusion of patients
during selection from the screened population may be imporlant for evaluating the impact of …

OBJECTIVES Estimate the effect of angiotensin converting enzyme (ACE) inhibitors on the
risk of sudden cardiac death (SCD) following myocardial infarction (MI). BACKGROUND …

Purpose: Angiotensin converting–enzyme (ACE) inhibitors decrease mortality after
myocardial infarction among patients with depressed left ventricular function. Beta blockers …

Background Results of randomized trials of angiotensin-converting enzyme inhibitors in
patients with coronary artery disease (CAD) and preserved left ventricular function are …

Objectives: This study sought to assess the efficacy of angiotensin-converting enzyme
inhibitors (ACEIs) in patients with coronary heart disease and preserved left ventricular (LV) …